genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Gastrointestinal Disorders
Intracellular Sensor May Lead to Novel Skin and Intestinal Therapies
Alzheimers
Alzheimer’s Biomarker Kit for Point-of-Care Testing Receives Grant
Neurological Disorders
Watching Neurons Make Decisions Could Inform Future Strategies for Neurological Disorders
DNA
Moderna, Generation Bio Launch Up-to-$1.9B Non-Viral Genetic Medicines Collaboration
Industry News
Cosmetics Get Sustainability Boost From L’Oreal and Geno
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
AgBio
Plants to Play Larger Role in Battle against COVID-19
Bioprocessing
Merck Biomanufacturing Optimization Sees Major Production Gains
Bioprocessing
Pharmaceutical Manufacturers Need to Stay Focused on Supply Chain Audit
Bioprocessing
Cell-Free Synthesis of Peptidomimetic Drugs by International Research Team
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Companies
Merck KGaA
Merck KGaA
23andMe
Abbvie
AdnaGen
Agilent Technologies
Alexion Pharmaceuticals
Amgen
Astellas
AstraZeneca
Audentes Therapeutics
Berkeley Lights
Bio-Rad Laboratories
Biogen
Cancer Genetics
Catalent
Charles RIver Laboratories
Dana-Farber Cancer Institute
deCODE genetics
Dicerna
Dimension Therapeutics
Exact Sciences
Foundation Medicine
GE Healthcare
GeneInsight
Gilead Sciences
GlaxoSmithKline
Halozyme Therapeutics
Hitachi High-Technologies
Horizon Discovery Group
Human Longevity
Illumina
Jackson Laboratory
Janssen Biotech
LabCorp
Maravai LifeSciences
MD Anderson
MDxHealth
MedImmune
Memorial Sloan Kettering Cancer Center
Merck & Co
Merck KGaA
NanoString Technologies
Novartis
Pathology
PerkinElmer
PersonalizeDx
Qiagen
RayBiotech
Roche
Sanofi
shire
Sigma-Aldrich
Synthego
Takeda
Thermo Fisher Scientific
UCB Biosciences
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Drug Discovery
Nektar Eliminates 70% of Workforce, 500+ Jobs, in Restructuring
Financing
EY Firepower Report: Biopharmas Choosing Collaborations over M&A
Merck KGaA
Looking Beyond Bioprocessing to China, eCommerce, New Tech, and Services
Merck KGaA
Broad Institute, MilliporeSigma to Offer Non-Exclusive Licenses to CRISPR IP
Merck KGaA
Merck KGaA to Expand Aubonne, Switzerland Manufacturing Site
Merck KGaA
Merck KGaA, Pfizer Join BioXcel-Nektar Collaboration, Creating Triple Combination Therapy for...
Merck KGaA
GSK to Co-Develop Merck KGaA’s Cancer Immunotherapy Candidate M7824 in $4.2B...
Merck KGaA
Licensing Deal Moves Merck KGaA, Vertex Further into Gene Editing-Based Drug...
Merck KGaA
Lundbeck to Acquire Prexton Therapeutics for Up-to-$1.1B
Merck KGaA
Roivant to Codevelop Poxel’s T2D Candidate Imeglimin in Up-to-$650M Partnership
Merck KGaA
Top 15 Bioprocessing Companies
Merck KGaA
Merck KGaA, Cancer Research UK, ICR Launch Three Drug Discovery Projects
Merck KGaA
Stanford Spinout Partners with Merck KGaA, Genentech in Cancer Studies of...
Merck KGaA
MilliporeSigma Opens Burlington, MA, Campus
Merck KGaA
Merck KGaA Plans €35M Expansion of Italian Manufacturing Site
1
2
Page 1 of 2
Scroll Up